Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

662 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Balancing Cancer Immunotherapy Efficacy and Toxicity.
Johnson DB, Jakubovic BD, Sibaud V, Sise ME. Johnson DB, et al. J Allergy Clin Immunol Pract. 2020 Oct;8(9):2898-2906. doi: 10.1016/j.jaip.2020.06.028. Epub 2020 Jun 26. J Allergy Clin Immunol Pract. 2020. PMID: 32599218 Free PMC article. Review.
PD-1/PD-L1 blockade in renal cell cancer.
Beckermann KE, Johnson DB, Sosman JA. Beckermann KE, et al. Among authors: johnson db. Expert Rev Clin Immunol. 2017 Jan;13(1):77-84. doi: 10.1080/1744666X.2016.1214575. Epub 2016 Jul 28. Expert Rev Clin Immunol. 2017. PMID: 27426025 Free PMC article. Review.
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade.
Johnson DB, Frampton GM, Rioth MJ, Yusko E, Xu Y, Guo X, Ennis RC, Fabrizio D, Chalmers ZR, Greenbowe J, Ali SM, Balasubramanian S, Sun JX, He Y, Frederick DT, Puzanov I, Balko JM, Cates JM, Ross JS, Sanders C, Robins H, Shyr Y, Miller VA, Stephens PJ, Sullivan RJ, Sosman JA, Lovly CM. Johnson DB, et al. Cancer Immunol Res. 2016 Nov;4(11):959-967. doi: 10.1158/2326-6066.CIR-16-0143. Epub 2016 Sep 26. Cancer Immunol Res. 2016. PMID: 27671167 Free PMC article.
Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma.
Betof AS, Nipp RD, Giobbie-Hurder A, Johnpulle RAN, Rubin K, Rubinstein SM, Flaherty KT, Lawrence DP, Johnson DB, Sullivan RJ. Betof AS, et al. Among authors: johnson db. Oncologist. 2017 Aug;22(8):963-971. doi: 10.1634/theoncologist.2016-0450. Epub 2017 May 5. Oncologist. 2017. PMID: 28476944 Free PMC article.
Emerging biomarkers for cancer immunotherapy in melanoma.
Axelrod ML, Johnson DB, Balko JM. Axelrod ML, et al. Among authors: johnson db. Semin Cancer Biol. 2018 Oct;52(Pt 2):207-215. doi: 10.1016/j.semcancer.2017.09.004. Epub 2017 Sep 14. Semin Cancer Biol. 2018. PMID: 28917578 Free PMC article. Review.
Toxicities Associated With PD-1/PD-L1 Blockade.
Wang DY, Johnson DB, Davis EJ. Wang DY, et al. Among authors: johnson db. Cancer J. 2018 Jan/Feb;24(1):36-40. doi: 10.1097/PPO.0000000000000296. Cancer J. 2018. PMID: 29360726 Free PMC article. Review.
Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection.
Tio M, Rai R, Ezeoke OM, McQuade JL, Zimmer L, Khoo C, Park JJ, Spain L, Turajlic S, Ardolino L, Yip D, Goldinger SM, Cohen JV, Millward M, Atkinson V, Kane AY, Ascierto PA, Garbe C, Gutzmer R, Johnson DB, Rizvi HA, Joshua AM, Hellmann MD, Long GV, Menzies AM. Tio M, et al. Among authors: johnson db. Eur J Cancer. 2018 Nov;104:137-144. doi: 10.1016/j.ejca.2018.09.017. Epub 2018 Oct 20. Eur J Cancer. 2018. PMID: 30347289 Free PMC article.
662 results